✦ LIBER ✦

Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid

✍ Scribed by Yasuto Takeuchi; Fusao Ikeda; Shin-ichi Fujioka; Toshiyuki Takaki; Toshiya Osawa; Tetsuya Yasunaka; Yasuhiro Miyake; Akinobu Takaki; Yoshiaki Iwasaki; Haruhiko Kobashi; Kazuhide Yamamoto; Tatsuya Itoshima

Book ID: 108954145
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 928 KB
Volume: 26
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2011.06737.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atorvastatin in patients with primary bi

Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid

✍ Tatjana Stojakovic; Csilla Putz-Bankuti; Günter Fauler; Hubert Scharnagl; Martin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

Statin therapy may target both hypercholesterolemia and cholestasis in primary biliary cirrhosis (PBC). However, little is known about the efficacy and safety of statins in PBC. The aim of this single-center study was therefore to prospectively examine the effects of atorvastatin on serum markers of

Changes in bile acid composition in pati

Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration

✍ Andrea Crosignani; Mauro Podda; Pier Maria Battezzati; Emanuela Bertolini; Massi 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 855 KB

We describe a detailed study of the effects of ursodeoxycholic acid administration on bile acid composition of the serum and bile of patients with primary biliary cirrhosis. Gas chromatography-mass spectrometry was used to analyze bile acids from 10 patients with primary biliary cirrhosis before and

Early biochemical response to ursodeoxyc

Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis

✍ Nobuaki Azemoto; Masanori Abe; Yosuke Murata; Yoichi Hiasa; Maho Hamada; Bunzo M 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 215 KB

Oral budesonide in the treatment of pati

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

✍ Paul Angulo; Roberta A. Jorgensen; Jill C. Keach; E. Rolland Dickson; Coleman Sm 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

Ursodeoxycholic acid (UDCA) is a safe and effective medical therapy for most patients with primary biliary cirrhosis (PBC). However, some patients show an incomplete response to UDCA therapy. Treatment with corticosteroids may be of benefit although at the expense of systemic side effects. Budesonid

Biochemical and immunologic effects of r

Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

✍ Masanobu Tsuda; Yuki Moritoki; Zhe-Xiong Lian; Weici Zhang; Katsunori Yoshida; K 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 904 KB

Does antimitochondrial antibody status a

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation

✍ W R Kim; J J Poterucha; R A Jorgensen; K P Batts; H A Homburger; E R Dickson; R 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

rum. 1 In the past decade, two treatment modalities have Approximately 5% to 10% of patients with features otherbeen shown to be effective in the treatment for PBC, dewise consistent with primary biliary cirrhosis (PBC) lack antipending on the stage of the disease. For patients with less mitochondri